IKZF1 and leukemia: Targeting Ikaros-regulated signaling pathways could be a highly effective therapeutic approach in high-risk leukemias that are characterized by Ikaros genetic inactivation (IKZF1 haploinsufficiency due to deletion of one IKZF1 allele).